Combining CADe and a Mucosal Exposure Device Provides Best Detection During Colonoscopy
Douglas K. Rex, MD, MASGE, reviewing Aniwan S, et al. Gastrointest Endosc 2022 Oct 8.
In a randomized controlled trial, 1245 participants aged 50 to 75 years were randomized to standard colonoscopy, standard colonoscopy plus an artificial intelligence (AI) detection program (CADe), standard colonoscopy with Endocuff (Olympus Corp, Tokyo, Japan) assistance (EAC), or CADe plus EAC. The adenoma detection rates (ADRs) in the control, CADe, EAC, and CADe plus EAC groups were 41.9%, 52.2%, 54%, and 58.8%, respectively. Adenomas per colonoscopy in the 4 respective groups were 0.76, 1.11, 1.18, and 1.31. The advanced ADRs (AADRs) for the 4 groups were 7.7%, 8.3%, 8.3%, and 13.6%, respectively. Only the group with the combination of CADe plus EAC had improved AADR compared with controls.
Note to readers: At the time we reviewed this paper, its publisher noted that it was not in final form and that subsequent changes might be made.
CITATION(S)
Aniwan S, Mekritthikrai K, Kerr SJ, et al. Computer-aided detection, mucosal exposure device, their combination, and standard colonoscopy for adenoma detection: a randomized controlled trial. Gastrointest Endosc 2022 Oct 8. (Epub ahead of print) (https://doi.org/10.1016/j.gie.2022.09.023)